ABSTRACT. Neurologic and audiologic sequelae produced by bilirubin toxicity are preventable by appropriately timed therapeutic intervention. To understand the timing and reversibility of the neural dysfunction that follows exposure to bilirubin, we recorded brainstem auditory evoked potentials (BAEI') in the Gunn rat model of bilirubin encephalopathy. Abnormal HAEP occur in jaundiced Gunn rats after injection of sulfadimethosine (sulfa) 100 mg/kg intraperitoneally, which displaces bilirubin from blood albumin binding sites and promotes the net transfer of bilirubin into brain tissue. Reversal of BAEI' abnormalities with injection of human serum albumin (IISII) 2 g/kg intraperitoneally was studied in 17-to 20-d-old jaundiced Gunn rats. One animal from each of 14 litters was randomly assigned to one of the follorving treatment groups: 1 ) sulfa alone, 2) sulfa + IlSA at 2 h, 3) sulfa + 11SA at 8 h, or 4) saline alone. BAEP were recorded in each rat before and 0.1, 4, 8, 24 , and 48 h after injection of sulfa or saline. BIIEP I-I1 interwave intervals increased in all sulfa groups ( p < lo-') to 0.27 ms (21%) above baseline a t 8 h for the two sulfa groups not receiving treatment before that time ( p = 0.0002), but increased less for the sulfa group given IISA at 2 h compared with untreated animals ( p = 0.02). Partial recovery of function occurred a t 23 and 48 h for both IISAtreated groups compared wit11 their 8-11 values ( p = 0.0001), and there was increased mortality at 23 h for the sulfa group not treated with IISA ( p < 0.001). ilmplitudes of BAEI' waves I, 11, and 111 decreased to 59 2 17%, 25 + 9%, and 9 + 9%, after sulfa; there was a protective effect of early treatment on waves 1 and I1 but not 111. Amplitude of wave I1 but not waves I and 111 recovered with IISA. Thus, therapeutic intervention with 1ISA a s late a s 8 h after acute bilirubin encephalopathy in this animal model promotes the recovery of neuropllysiologic function a s effectively a s intervention at 2 h. This indicates that a hypothesized "critical period" for recovery of auditory brainstem function after acute bilirubin encephalopathy may extend beyond 8 h. Despite advances in their care, human newborns continue to be at risk of incurring brain damage and hearing loss. Bilirubin toxicity is one potentially preventable cause of these disorders. The auditory nervous system is especially vulnerable to acute bilirubin toxicity (I). BAEP provide an extremely sensitive measure of auditory nervous system function and are abnormal in hypcrbilirubinemic infants (2-6).
The significant neurologic and audiologic scquelae produced by bilirubin toxicity may be preventable by appropriately timed therapeutic intervention, and treatment for hyperbilirubinemia corrects ncurophysiologic abnormalities. For example, abnormal BAEP in hyperbilirubinemic infants normalize with phototherapy or exchange transfusion (4. 6). However, the degree and extent of reversibility of bilirubin neurotoxicity has not been systematically explored thus far.
The Gunn rat is the classic animal model for bilirubin enccphalopathy (7) and lacks the enzyme glucuronyl transferase (8).
which is immature in human neonates and contributes to physiologic jaundice of the ncwborn. In the Gunn rat animal model. the pathologic lesions associated with bilirubin encephalopathy include damage to central auditory structures. especially the cochlear nuclei and inferior colliculi, and arc similar to those found in humans (9). Changes in learning behavior (10) . neurologic function (1 I), and BAEP (12) also parallel the human condition. Ncurophysiologic abnormalities include changes in BAEP waves arising from the cochlear nuclei and more central pathways (12-1 5).
Bilirubin in blood normally is bound to albumin. but it can be displaced by drugs such as sulfonamides. which compete for binding sitcs on albumin (16) . When the long-acting sulfonamide. sulfadimethoxine, is administered ip to young jj Gunn rats. neuropathologic lesions that resemble human kernicterus (17) and BAEP abnormalities (18) arc produced. BAEP changes include increased latencies for waves I1 and Ill, increased 1-11 and 1-111 1W1, and reduced amplitudes of waves I1 and Ill.
Observations of occasional spontaneous reversal of BAEP abnormalities induced by injecting sulfa prompted systematic studies of the reversibility of these ncurophysiologic abnormalities. T o create a reproducible model of reversibility. HSA was administered. HSA binds bilirubin and promotes the net transfer of bilirubin out of brain tissue (19). The partial reversal of the increased BAEP latencies after the administration of HSA 2 h after treatment with sulfa was previously reported (18) .
In the present study, it was hypothesized that a critical time exists beyond which neurophysiologic abnormalities bccome irreversible in acute bilirubin enccphalopathy. In this experiment, animals rcccivcd HSA 2 or 8 h after sulfa. The carly treatment was chosen to be 2 h because a preliminary study showed no difference in BAEP at 8 h with HSA given 0, 1, 2, and 4 h after sulfa, and the late treatment was chosen to be 8 h because it was hypothesized that delay of treatment past 8 h would produce unacceptably high mortality. BAEP were recorded bcfore, immediately after (0.1 h), and 4, 8. 24, and 48 h after injection of sulfa. The BAEP test times of 0.1. 4, and 8 h wcrc chosen to correspond with the times of a previous study (IS), and 24-and 48-h times were added to examine more delayed effects. A difference between treatment carly (2 h) and later (8 h) after acute, sulfa-induced bilirubin toxicity was hypothesized.
MATERIALS AND IvlETIIODS
B.4EP ~tir)~rrllt.s und rccor~litlg. The methods havc been previously described (18) . Briefly, after intramuscular administration of ketamine (60 mg/kg) and acepromazine (6 mg/kg) anesthesia. platinum needle electrodes (Grass Instruments. Quincy, MA) were inserted S.C. at the vertex and over the right and left mastoid bones. Supplemental anesthesia. one quarter to one half the original dose, was given during the experiments as needed to prevent muscle activity, which was monitored continuously from the scalp electrodes. Rectal temperature was maintained bctween 37.0 and 372°C for 10 min beforc and during BAEP recordings. Scalp electrical activity was amplified x lo5, filtered from 30 to 3000 Hz, and averaged on a Nicolet 1170 Evoked Potential Averaging System (Nicolet Instruments, Madison. WI) for 10.24 ms poststimulus. The stimuli wcrc 100-ps clicks at 75 dB sound pressure level delivered at a ratc of 33.5 clicks/s by a Sony Walkman 4LIS spcaker centered over the right external car canal just touching the pinna. The left ear was plugged with Audalin earmold impression material (Esschem Company, Essington. PA) to minimize stimulation of the contralateral ear. All recordings were done in a sound-attenuatcd booth (model AC-3, Industrial Acoustic Company, New York. NY). Each BAEP was derived from the response to 2048 clicks. replicated, and plotted separately. The two replications were then digitally added and used to obtain the latencies and amplitudes of BAEP pcaks. The largest replicable peak was chosen: if there were bifid pcaks, the later peak was chosen.
E.~~~crit)ic~t~t.s. T o create a rcproducible model of rcversibility, HSA (Sigma Chemical Company, St. Louis. MO) was administered, because other therapies ( c .~. exchange transfusions and phototherapy) are technically difficult in infant rats. Preliminary trials indicated that a dose of 2 g/kg HSA diluted in 5% dextrose to a conccntration of 100 mg/mL was the largest single dose that per group). HSA dose was 2 mg/kg ip. In the sulfa and saline only groups. an cqual volume of 5% dcxtrose (the dilucnt for HSA) was given 2 11 aftcr injection.
Dntu N I I~I~: S~. Y .
The latencies of wavcs I, 11. and 111 werc scorcd. and the values were used to dcrivc IWI of 1-11 (1-11 IWI = latency 11 -latency I) and 11-111. For analysis, thc contralateral mastoid to ipsilatcral mastoid electrode montage was chosen, inasniuch as it was previously found that this montage yieldcd the clearest distinction between wavcs ( I 5). The two rcplications. cach the response to 2048 stimuli. wcrc digitally addcd and scorcd with a digital cursor. The largest replicable pcak was chosen: if there were bifid pcaks, the later pcak was chosen. Changes in BAEP latencies and IWI were calculated by subtract- Fig. 2 . Change of wave I latency and 1-11 and 11-Ill IWI (mean SEM) in jj Gunn rats given 100 mg/kg sulfa alone ( a ) . sulfa followed by 2 g/kg HSA 2 h (0) or 8 h ( 0 ) after sulfa. and saline alonc (H). :I. Change of wave I latency. There was no significant difference between groups at 4 and 8 h, but wavc I latcncy increased at both 24 and 48 h. The majority of animals given sulfa alone and not treated with 11SA were dead at 24 h. B, Change of 1-11 IWI. Notc the 1-11 increase in all groups givcn sulfa comparcd with thc saline controls. However. at 8 I1 after sulfa, the group given HSA at 2 h showed lcss severe abnormality than the two groups not givcn HSA before 8 h. Differences at 8 h between the two groups given HSA are no longer apparent at 24 and 48 h. C. Change of 11-111 IWI. Note the 11-111 increase in all groups givcn sulfa compared with the saline controls and partial rccovcry at 24 and 48 h in both sulfa groups receiving HSA. There were no significant differences between groups givcn HSA at 2 v s 8 h aftcr sulfa. 48 h.
Wave 111 (Fig. 3C ) similarly declined to 9.3 2 8.7% of baseline in the groups treated with only sulfa for 5 8 h. There was no evidence of protection of wave 111 amplitude by early HSA treatment and little recovery at 24 and 48 h.
DISCUSSION
The baseline values for these jj rats are similar to those reported previously (12). Prolongation of the 1-11 and 1-111 IWI and dete- Fig. 3 . Change of amplitude of waves I, 11, and 111 (mean + SEhl) in jj Gunn rats given 100 mg/kg sulfa alonc ( a ) , sulfa follo\ved by 2 g/kg HSA 3 h (0) or 8 h (0) aftcr sulfa, and saline alone (H). ..I. BAEP wave 1 amplitude compared with baseline. Notc the dccrcasc in anlplitude of wave I in animals givcn sulfa and the partial protection with carly (2-11) HSA treatment. U . Change in amplitude of wave 11. Wave I1 amplitude decreased in all sulfa-treated groups. and the group treated with HSA at 2 h had lcss of a decrease in amplitude than either those trcatcd at 8 h or thosc not treated with sulfa. Notc the recovery of wave I1 amplitude in both HSA-treated groups. C: Change in amplitude of wavc 111 in salinc-and sulfa-treated jj Gunn rats compared with baselinc. Note the decrease in wavc 111 amplitude for a11 sulpa-treated groups with no recovery aftcr HSA administration at either 7 or 8 h aftcr sulfa.
rioration of amplitudes of BAEP waves I1 and 111 wcrc seen 4 and 8 h after sulfonamide injection as previously shown ( 1 8). In addition, there wcrc changes in wave I and the 11-111 IWI in jj rats given sulfonamide. These additional abnormalities may have resulted from a greater power to detect differences with the larger sample size of this study or from a difference in our Gunn rat colony over time, resulting in rats with greater serum bilirubin levels at the start of the study and thcrcfore more bilirubin available to be displaced into brain tissue.
These studies show that some of the neurophysiologic abnormalities occurring after sulfa-induced bilirubin toxicity are re- time bilirubin toxicity may produce permanent damage either by poisoning the metabolic machinery of neurons long enough for metabolic damage to become irreversible or by becoming irreversibly bound to brain tissue.
Although we demonstrated reversibility of BAEP, these responses d o not fully recover and thus some irreversible damage may have occurred. However, the period of follow-up was only 48 h in these studies. A longer follow-up pcriod may have allowed more time for recovery.
These studies indicate that bilirubin-induced neurophysiologic dysfunction is at least partially reversible. The phenomenon occurs spontaneously in a minority o f j j animals given sulfa and occurs more consistently when HSA is given to promote the net transfer of bilirubin out of brain tissue. These experiments indicate that BAEP o f j j Gunn rats given sulfa may be used to study functional recovery of the CNS after bilirubin toxicity. more apparent recovery at 34 h with some measures, c .~. wave I1 amplitude or 1-11 IWI, statistically significant differences between early and late HSA treatment were generally not seen at 48 h. This indicates that the hypothesized "critical period" for recovery of auditory brainstem function after acute bilirubin neurotoxicity may extend beyond 8 h.
Total recovery was seen occasionally in jj rats given sulfonamide. Partial recovery of abnormal BAEP was seen for most treated animals, but total recovery was seen only in wave I1 amplitude.
The BAEP abnormalities produced by giving sulfa to jj Gunn rats are likely to be due to the net transfer of bilirubin from the blood into brain tissue (19). Occasionally after injection with sulfa, BAEP abnormalities in jj rats spontaneously reverse, perhaps due to the excretion of the sulfonamide and the transfer of bilirubin from brain tissue back to the circulation. Bilirubin neurotoxicity may be reversible for a limited time, and after this
